Table II.
Relative expression | ||||
---|---|---|---|---|
Gene | C | CH | IH | IHH |
HMGB1 | 0.61±0.24 | 1.14±0.35a | 1.30±0.40a | 1.10±0.42a |
IL-6 | 0.99±0.59 | 1.39±1.16 | 1.53±0.44 | 1.17±0.93 |
PPAR | 1.04±0.07 | 1.69±0.42a | 2.66±0.59a | 1.73±0.34a |
RAGE | 1.15±0.13 | 1.71±0.54 | 2.47±0.85a | 1.30±0.47 |
NF-κB | 3.27±0.77 | 3.54±1.54 | 3.14±1.25 | 2.94±1.15 |
TLR4 | 1.13±0.59 | 1.23±0.52 | 0.81±0.25 | 1.06±0.62 |
SIRT1 | 1.03±0.07 | 0.88±0.21 | 0.94±0.29 | 0.73±0.27b |
TNF-α | 0.92±0.52 | 1.75±1.27a | 3.34±2.56a | 2.06±0.86a |
P<0.05 vs. C
P<0.05 vs. C. C, control; CH, continuous hypoxia; IH, intermittent hypoxia; IHH, intermittent hypoxia with hypercapnia; HMGB1, high mobility group box 1 protein; IL, interleukin; PPAR, peroxisome proliferator-activated receptor; RAGE, receptor for advanced glycosylation end products; NF, nuclear factor; TLR4, toll-like receptor 4; SIRT1, NAD-dependent deacetylase sirtuin-1; TNF, tumor necrosis factor.